Preliminary microbiological and pharmacological evaluation of 6-(R-alpha-amino-3-thienylacetamido) penicillanic acid (BL-P 875).
D000667:Ampicillin / Q000494:pharmacology; D000818:Animals; D001419:Bacteria / Q000187:drug effects; D004355:Drug Stability; D004927:Escherichia coli Infections / Q000188:drug therapy; D007710:Klebsiella Infections / Q000188:drug therapy; D008297:Male; D051379:Mice; D010146:Pain; D010406:Penicillins / Q000009:adverse effects / Q000097:blood / Q000138:chemical synthesis / Q000494:pharmacology* / Q000627:therapeutic use / Q000633:toxicity / Q000652:urine; D011512:Proteus Infections / Q000188:drug therapy; D051381:Rats; D012480:Salmonella Infections / Q000188:drug therapy
D010406:Penicillins; D000667:Ampicillin